Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome

Annals of Surgery

Volumn 225, Issue 1, 1997, Pages 88-96

  Lars, Eilegård ^a   Ingvar, Bosaeus ^a   Nordgren, Svante ^a   Bengt Åke , Bengtsson ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; PLACEBO; POTASSIUM; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BODY COMPOSITION; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; CROSSOVER PROCEDURE; DISEASE ACTIVITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FLUID THERAPY; GYNECOMASTIA; HUMAN; LEAN BODY WEIGHT; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT BOWEL SYNDROME; SUBCUTANEOUS DRUG ADMINISTRATION; SUPPLEMENTATION; TOTAL BODY POTASSIUM; TOTAL BODY WATER;

EID: 0031033302     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199701000-00010     Document Type: Article

References (19)

1. Ziegler TR, Gatzen C, Wilmore DW, Strategies for attenuating protein-cataboic responses in the critically ill. Annu Rev Med 1994; 45:459-480.
2. Byrne TA, Morrisey TB, Gutzen G. et al. Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring nutritional rehabilitation, Ann Surg 1993; 218:400-416.
3. Byrne TA, Persinger RL, Young LS, et al. A new treatment for patients with short-bowel syndrome. Ann Surg 1995; 222:243-255.
4. Brummer RJ, Rosen T. Bengtsson BA. Evaluation of different methods of determining body composition, with special reference to growth hormone-related disorders, Acta Endocrinol (Copenh) 1993; 128:30-36.
5. Sandberg AS, Andersson H, Hallgren B. et al. Experimental model for in vivo determination of dietary fibre and its effects on the absorption of nutrients in the small intestine. Br J Nutr 1981; 45:283-294.
6. Catignani GL. Simultaneous determination of retinal and alfa-to-copherolin serum or plasma by liquid chromatography. Clin Chem 1983; 29:708-712.
7. Booth IW. Enteral nutrition as primary therapy in short bowel syndrome. Gut 1994; 35:S69-S72.
8. Andersson H. Bosaeus I, Brummer RJ, et al. Nutritional consequenses of extensive bowel resection. Dig Dis 1986; 4:193-202.
9. Brevinge H, Berglund B, Bosaeus J, et al. Working capacity in patients undergoing proctocolectomy and small bowel resection due to Crohn's disease. Br J Surg 1995; 82:1040-1045.
10. Kaiser FE, Silver AJ, Morley JE. The effect of recombinant human growth hormone on malnourished older individuals. J Am Geriatr Soc 1991; 39:235-240.
11. Ward HC, Halliday D. Sim AJW. Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg 1987; 206:56-61.
12. Ziegler TR, Rombeau JL, Young LS, et al. Recombinant human growth hormone enhances the metabolic efficacy of patenterai nutrition: a double-blind, randomized controlled study. J Clin Endocrinol Metab 1992; 74:865-873.
13. Rudman D, Feller AG, Nagraj HS, et al, Effects of human growth hormone in men over 60 years old, N Engl J Med 1990; 323:1-6.
14. Binnerts A, Wilson JHP. Lamberts SWJ, The effects of human grovth hormone administration in elderly adults with recent weight loss. J Clin Endocrinol Metab 1988; 67:1312-1316.
15. Jiang ZM, He GZ, Zhang SY, et al. Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation. Ann Surg 1989; 210:513-524.
16. Salomon F, Cuneo RC, Hesp R, Sönksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989; 321:1797-1803.
17. Hawker FH, Stewart PM, Baxter RC, et al. Relationship between somatomedin-C/insulin-like growth factor I levels to conventional nutritional indices in critically ill patients. Crit Care Med 1987; 15:732-736.
18. Bengtsson B, Eden S. Lönn L, et al, Treatment of adults with growth hormone (GH)deficieney with recombinant human GH. J Clin Endocrinol Metab 1993; 76:309-317.
19. Rosen T, Johannsson G. Hallgren P, et al. Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults. Endocrinology Metab 1994 1:55-66.